These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35542585)

  • 1. Targeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapy.
    Xia Y; Wang C; Xu T; Li Y; Guo M; Lin Z; Zhao M; Zhu B
    RSC Adv; 2018 Jan; 8(4):1917-1926. PubMed ID: 35542585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy.
    Xia Y; Xu T; Wang C; Li Y; Lin Z; Zhao M; Zhu B
    Int J Nanomedicine; 2018; 13():143-159. PubMed ID: 29317822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of siRNA using RGDfC-conjugated functionalized selenium nanoparticles for anticancer therapy.
    Xia Y; Lin Z; Li Y; Zhao M; Wang C; Guo M; Zhang B; Zhu B
    J Mater Chem B; 2017 Sep; 5(33):6941-6952. PubMed ID: 32264343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized selenium nanoparticles for targeted siRNA delivery silence Derlin1 and promote antitumor efficacy against cervical cancer.
    Xia Y; Tang G; Wang C; Zhong J; Chen Y; Hua L; Li Y; Liu H; Zhu B
    Drug Deliv; 2020 Dec; 27(1):15-25. PubMed ID: 31830840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo.
    Xia Y; Tang G; Guo M; Xu T; Chen H; Lin Z; Li Y; Chen Y; Zhu B; Liu H; Cao J
    Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110594. PubMed ID: 32204058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeted delivery of siRNA to silence Sox2 gene expression enhances therapeutic response in hepatocellular carcinoma.
    Xia Y; Tang G; Chen Y; Wang C; Guo M; Xu T; Zhao M; Zhou Y
    Bioact Mater; 2021 May; 6(5):1330-1340. PubMed ID: 33210026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy.
    Xia Y; Chen Y; Hua L; Zhao M; Xu T; Wang C; Li Y; Zhu B
    Int J Nanomedicine; 2018; 13():6929-6939. PubMed ID: 30464451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
    Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
    Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy.
    Wang C; Xia Y; Huo S; Shou D; Mei Q; Tang W; Li Y; Liu H; Zhou Y; Zhu B
    Int J Nanomedicine; 2020; 15():9759-9770. PubMed ID: 33304100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma.
    Xia Y; Zhong J; Zhao M; Tang Y; Han N; Hua L; Xu T; Wang C; Zhu B
    Drug Deliv; 2019 Dec; 26(1):1-11. PubMed ID: 31928356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-targeted selenium nanoparticles deliver therapeutic siRNA to improve hepatocellular carcinoma therapy.
    Xia Y; Zhao M; Chen Y; Hua L; Xu T; Wang C; Li Y; Zhu B
    RSC Adv; 2018 Jul; 8(46):25932-25940. PubMed ID: 35541982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging.
    Yu Q; Liu Y; Cao C; Le F; Qin X; Sun D; Liu J
    Nanoscale; 2014 Aug; 6(15):9279-92. PubMed ID: 24986368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional selenium nanoparticles: Chiral selectivity of delivering MDR-siRNA for reversal of multidrug resistance and real-time biofluorescence imaging.
    Chen Q; Yu Q; Liu Y; Bhavsar D; Yang L; Ren X; Sun D; Zheng W; Liu J; Chen LM
    Nanomedicine; 2015 Oct; 11(7):1773-84. PubMed ID: 25959925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles.
    Huang Y; He L; Liu W; Fan C; Zheng W; Wong YS; Chen T
    Biomaterials; 2013 Sep; 34(29):7106-16. PubMed ID: 23800743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.
    Xia Y; Xu T; Zhao M; Hua L; Chen Y; Wang C; Tang Y; Zhu B
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells.
    Liu T; Zeng L; Jiang W; Fu Y; Zheng W; Chen T
    Nanomedicine; 2015 May; 11(4):947-58. PubMed ID: 25680543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
    Zou J; Su S; Chen Z; Liang F; Zeng Y; Cen W; Zhang X; Xia Y; Huang D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3456-3464. PubMed ID: 31469318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA-Loaded Hydroxyapatite Nanoparticles for
    Luo D; Xu X; Iqbal MZ; Zhao Q; Zhao R; Farheen J; Zhang Q; Zhang P; Kong X
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro.
    Xia Y; You P; Xu F; Liu J; Xing F
    Nanoscale Res Lett; 2015 Dec; 10(1):1051. PubMed ID: 26334544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gracilaria lemaneiformis polysaccharide as integrin-targeting surface decorator of selenium nanoparticles to achieve enhanced anticancer efficacy.
    Jiang W; Fu Y; Yang F; Yang Y; Liu T; Zheng W; Zeng L; Chen T
    ACS Appl Mater Interfaces; 2014 Aug; 6(16):13738-48. PubMed ID: 25073123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.